Filed: 2/13/2026ACC: 0001856083-26-000001
📋 What this filing means
DEEP TRACK CAPITAL, LP filed this quarterly 13F‑HR report disclosing 55 equity positions with a total reported market value of $5.61B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
55
Positions
$5.61B
Total AUM (reported)
206.11M
Total Shares
Allocation by class
COM$2.95B52.6%
STATE STREET SPD$1.22B21.7%
COM NEW$621.63M11.1%
SPONSORED ADS$386.65M6.9%
CL A$146.95M2.6%
SHS$75.09M1.3%
COM SHS$74.63M1.3%
Portfolio Concentration
Top 3$1.80B32.1%
4–10$1.58B28.1%
11–25$1.48B26.5%
Rest$751.51M13.4%
Top 3 weight
32.1%
Top 10 weight
60.1%
Voting Authority Distribution
Total shares with voting rights: 206.11M
Sole
Full voting authority
206.11M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole55
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings55
Rows:
SPDR SERIES TRUST
SOLEShares10M
TypeSH
Market value$1.22B
21.74%
Sole
10M
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares11.53M
TypeSH
Market value$293.02M
5.22%
Sole
11.53M
Shared
0.00
None
0.00
GUARDANT HEALTH INC
SOLEShares2.80M
TypeSH
Market value$285.99M
5.10%
Sole
2.80M
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares4.11M
TypeSH
Market value$285.97M
5.10%
Sole
4.11M
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
SOLEShares3M
TypeSH
Market value$245.97M
4.39%
Sole
3M
Shared
0.00
None
0.00
DYNAVAX TECHNOLOGIES CORP
SOLEShares15.73M
TypeSH
Market value$241.87M
4.31%
Sole
15.73M
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares3.34M
TypeSH
Market value$212.03M
3.78%
Sole
3.34M
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares1.15M
TypeSH
Market value$210.04M
3.74%
Sole
1.15M
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares7.75M
TypeSH
Market value$194.68M
3.47%
Sole
7.75M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares4M
TypeSH
Market value$184.56M
3.29%
Sole
4M
Shared
0.00
None
0.00
MAZE THERAPEUTICS INC
SOLEShares4.25M
TypeSH
Market value$175.93M
3.14%
Sole
4.25M
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares2.82M
TypeSH
Market value$142.86M
2.55%
Sole
2.82M
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares2.30M
TypeSH
Market value$136.69M
2.44%
Sole
2.30M
Shared
0.00
None
0.00
IONIS PHARMACEUTICALS INC
SOLEShares1.70M
TypeSH
Market value$134.49M
2.40%
Sole
1.70M
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares7.04M
TypeSH
Market value$133.48M
2.38%
Sole
7.04M
Shared
0.00
None
0.00
MBX BIOSCIENCES INC
SOLEShares3.25M
TypeSH
Market value$102.50M
1.83%
Sole
3.25M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares8.07M
TypeSH
Market value$97.97M
1.75%
Sole
8.07M
Shared
0.00
None
0.00
GRAIL INC
SOLEShares1.02M
TypeSH
Market value$87.54M
1.56%
Sole
1.02M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares2.52M
TypeSH
Market value$78.57M
1.40%
Sole
2.52M
Shared
0.00
None
0.00
LB PHARMACEUTICALS INC
SOLEShares3.35M
TypeSH
Market value$74.63M
1.33%
Sole
3.35M
Shared
0.00
None
0.00
IMMUNOCORE HLDGS PLC
SOLEShares2M
TypeSH
Market value$69.56M
1.24%
Sole
2M
Shared
0.00
None
0.00
ORUKA THERAPEUTICS INC
SOLEShares2.16M
TypeSH
Market value$65.52M
1.17%
Sole
2.16M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares810.14K
TypeSH
Market value$61.97M
1.10%
Sole
810.14K
Shared
0.00
None
0.00
CORMEDIX INC
SOLEShares5.27M
TypeSH
Market value$61.34M
1.09%
Sole
5.27M
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares4.61M
TypeSH
Market value$60.76M
1.08%
Sole
4.61M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR SERIES TRUSTSOLE | STATE STREET SPD | 10M | SH | $1.22B 21.74% | 10M | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 11.53M | SH | $293.02M 5.22% | 11.53M | 0.00 | 0.00 |
GUARDANT HEALTH INCSOLE | COM | 2.80M | SH | $285.99M 5.10% | 2.80M | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | SPONSORED ADS | 4.11M | SH | $285.97M 5.10% | 4.11M | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCSOLE | COM | 3M | SH | $245.97M 4.39% | 3M | 0.00 | 0.00 |
DYNAVAX TECHNOLOGIES CORPSOLE | COM NEW | 15.73M | SH | $241.87M 4.31% | 15.73M | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 3.34M | SH | $212.03M 3.78% | 3.34M | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 1.15M | SH | $210.04M 3.74% | 1.15M | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 7.75M | SH | $194.68M 3.47% | 7.75M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 4M | SH | $184.56M 3.29% | 4M | 0.00 | 0.00 |
MAZE THERAPEUTICS INCSOLE | COM | 4.25M | SH | $175.93M 3.14% | 4.25M | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | CL A | 2.82M | SH | $142.86M 2.55% | 2.82M | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 2.30M | SH | $136.69M 2.44% | 2.30M | 0.00 | 0.00 |
IONIS PHARMACEUTICALS INCSOLE | COM | 1.70M | SH | $134.49M 2.40% | 1.70M | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 7.04M | SH | $133.48M 2.38% | 7.04M | 0.00 | 0.00 |
MBX BIOSCIENCES INCSOLE | COM | 3.25M | SH | $102.50M 1.83% | 3.25M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 8.07M | SH | $97.97M 1.75% | 8.07M | 0.00 | 0.00 |
GRAIL INCSOLE | COM | 1.02M | SH | $87.54M 1.56% | 1.02M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 2.52M | SH | $78.57M 1.40% | 2.52M | 0.00 | 0.00 |
LB PHARMACEUTICALS INCSOLE | COM SHS | 3.35M | SH | $74.63M 1.33% | 3.35M | 0.00 | 0.00 |
IMMUNOCORE HLDGS PLCSOLE | ADS | 2M | SH | $69.56M 1.24% | 2M | 0.00 | 0.00 |
ORUKA THERAPEUTICS INCSOLE | COM | 2.16M | SH | $65.52M 1.17% | 2.16M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 810.14K | SH | $61.97M 1.10% | 810.14K | 0.00 | 0.00 |
CORMEDIX INCSOLE | COM | 5.27M | SH | $61.34M 1.09% | 5.27M | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 4.61M | SH | $60.76M 1.08% | 4.61M | 0.00 | 0.00 |
Page 1 of 3